1. Home
  2. CRNX vs STNG Comparison

CRNX vs STNG Comparison

Compare CRNX & STNG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Crinetics Pharmaceuticals Inc.

CRNX

Crinetics Pharmaceuticals Inc.

HOLD

Current Price

$36.66

Market Cap

3.9B

Sector

Health Care

ML Signal

HOLD

Logo Scorpio Tankers Inc.

STNG

Scorpio Tankers Inc.

HOLD

Current Price

$80.23

Market Cap

4.0B

ML Signal

HOLD

Company Overview

Basic Information
Metric
CRNX
STNG
Founded
2008
2009
Country
United States
Monaco
Employees
N/A
24
Industry
Biotechnology: Pharmaceutical Preparations
Marine Transportation
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
3.9B
4.0B
IPO Year
2018
N/A

Fundamental Metrics

Financial Performance
Metric
CRNX
STNG
Price
$36.66
$80.23
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
8
6
Target Price
$76.75
$83.33
AVG Volume (30 Days)
1.3M
1.0M
Earning Date
05-07-2026
05-05-2026
Dividend Yield
N/A
2.22%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,039,000.00
N/A
Revenue This Year
$720.10
$4.31
Revenue Next Year
$184.67
N/A
P/E Ratio
N/A
$10.06
Revenue Growth
N/A
N/A
52 Week Low
$25.83
$37.96
52 Week High
$57.99
$87.39

Technical Indicators

Market Signals
Indicator
CRNX
STNG
Relative Strength Index (RSI) 45.46 49.24
Support Level $33.19 $80.14
Resistance Level $37.23 $81.85
Average True Range (ATR) 2.17 2.96
MACD -0.18 -0.68
Stochastic Oscillator 28.47 26.19

Price Performance

Historical Comparison
CRNX
STNG

About CRNX Crinetics Pharmaceuticals Inc.

Crinetics Pharmaceuticals Inc is a commercial-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its main product, Palsonify (paltusotine), is a once-daily, oral treatment approved by the FDA for adults with acromegaly who have had an inadequate response to surgery and/or for whom surgery is not an option. Additionally, the company's development pipeline includes several programs, including a late-stage investigational candidate, atumelnant, currently in development for CAH and ADCS, and CRN09682, a NDC candidate that is being developed to treat SST2-expressing NETs and other SST2-expressing solid tumors.

About STNG Scorpio Tankers Inc.

Scorpio Tankers Inc is a provider of marine transportation of petroleum products. It owned, lease financed, or chartered in vessels spanning three different vessel segments Handymax, MR, and LR2. The company's fleet of tankers is the eco-friendly, and newest fleet on the water hauling clean petroleum products. It provides seaborne transportation of crude oil and refined petroleum products. The company generates the majority of its revenue from LR2.

Share on Social Networks: